Matthew P. Goetz

Also affiliated with Mayo Clinic in Arizona

Biochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 7%percentile

0.104Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Lessons learned from a candidate gene study investigating aromatase inhibitor treatment outcome in breast cancer

npj Breast Cancer(2025)10.1038/s41523-025-00733-y

Top 78%

0.104DataRank

Top 78%1 citations

Stefan Winter, Wing‐Yee Lo, Kyriaki Michailidou, Manjeet K. Bolla, Renske Keeman +69 more

Papers

Driven by 58 papers — median percentile 22. Top paper: “Patient-Reported Cognitive Impairment Among Women With Early Breast Cancer Randomly Assigned to Endocrine Therapy Alone Versus Chemoendocrine Therapy: Results From TAILORx”.

Patient-Reported Cognitive Impairment Among Women With Early Breast Cancer Randomly Assigned to Endocrine Therapy Alone Versus Chemoendocrine Therapy: Results From TAILORx

Journal of Clinical Oncology(2020)10.1200/jco.19.01866

N/A

3.5DataRank · unranked

102 citations

Robert J. Gray, Joseph A. Sparano, Timothy J. Whelan, Sofia F. Garcia, Betina R. Yanez +14 more

Inhibition of ATM Induces Hypersensitivity to Proton Irradiation by Upregulating Toxic End Joining

Cancer Research(2021)10.1158/0008-5472.can-20-2960

N/A

1.7DataRank · unranked

46 citations

Michelle E. Howard, Xinyi Tu, Qian Zhu, Janet M. Denbeigh, Nicholas B. Remmes +12 more

Evaluation of Alisertib Alone or Combined With Fulvestrant in Patients With Endocrine-Resistant Advanced Breast Cancer

JAMA Oncology(2023)10.1001/jamaoncol.2022.7949

N/A

1.4DataRank · unranked

52 citations

Vera J. Suman, Antonino B. D’Assoro, Jodi M. Carter, Karthik V. Giridhar, Brendan P. McMenomy +18 more

Distinct spatial immune microlandscapes are independently associated with outcomes in triple-negative breast cancer

Nature Communications(2023)10.1038/s41467-023-37806-0

N/A

1.4DataRank · unranked

44 citations

Saranya Chumsri, Douglas Hinerfeld, Yaohua Ma, Xue Wang, David Zahrieh +21 more

Pharmacogenomics of aromatase inhibitors in postmenopausal breast cancer and additional mechanisms of anastrozole action

JCI Insight(2020)10.1172/jci.insight.137571

N/A

1.3DataRank · unranked

45 citations

James N. Ingle, Tanda M. Dudenkov, Krishna R. Kalari, Erin E. Carlson, Jie Na +12 more

Alliance A011801 (compassHER2 RD): Postneoadjuvant T-DM1 + Tucatinib/Placebo in Patients with Residual HER2-Positive Invasive Breast Cancer

Future Oncology(2021)10.2217/fon-2021-0753

N/A

0.901DataRank · unranked

30 citations

Karla V. Ballman, Linda McCall, Anuhya Kommalapati, Tyler Zemla, Anna Weiss +12 more

Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancer

Breast Cancer Research(2020)10.1186/s13058-020-01286-7

N/A

0.727DataRank · unranked

21 citations

Xiaonan Hou, Mary J. Kuffel, Vera J. Suman, Tanya L. Hoskin, Kathryn E. Reinicke +17 more

Estrogen receptor beta repurposes EZH2 to suppress oncogenic NFκB/p65 signaling in triple negative breast cancer

npj Breast Cancer(2022)10.1038/s41523-022-00387-0

N/A

0.714DataRank · unranked

19 citations

Jodi M. Carter, Tanya L. Hoskin, Vera J. Suman, Malayannan Subramaniam, Michael J. Emch +22 more

Evaluation of Germline Genetic Testing Criteria in a Hospital-Based Series of Women With Breast Cancer

Journal of Clinical Oncology(2020)10.1200/jco.19.02190

N/A

0.709DataRank · unranked

112 citations

Chunling Hu, Steven N. Hart, Nicholas Boddicker, Eric C. Polley, Jie Na +22 more

Preclinical safety assessment of MV-s-NAP, a novel oncolytic measles virus strain armed with an H. pylori immunostimulatory bacterial transgene

Molecular Therapy — Methods & Clinical Development(2022)10.1016/j.omtm.2022.07.014

N/A

0.701DataRank · unranked

22 citations

Michael B. Steele, Ianko Iankov, Susanna C. Concilio, Arun Ammayappan, Brad Bolon +8 more

Phase III Randomized, Placebo-Controlled Trial of Endocrine Therapy ± 1 Year of Everolimus in Patients With High-Risk, Hormone Receptor–Positive, Early-Stage Breast Cancer

Journal of Clinical Oncology(2024)10.1200/jco.23.02344

N/A

0.646DataRank · unranked

17 citations

Jieling Miao, Lajos Pusztai, Matthew P. Goetz, Priya Rastogi, Patricia A. Ganz +17 more

Implementation of preemptive DNA sequence–based pharmacogenomics testing across a large academic medical center: The Mayo-Baylor RIGHT 10K Study

Genetics in Medicine(2022)10.1016/j.gim.2022.01.022

N/A

0.637DataRank · unranked

69 citations

Steven E. Scherer, Suzette J. Bielinski, Donna M. Muzny, Leila A. Jones, John L. Black +95 more

MRI Radiomics for Assessment of Molecular Subtype, Pathological Complete Response, and Residual Cancer Burden in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy

Academic Radiology(2020)10.1016/j.acra.2020.10.020

N/A

0.624DataRank · unranked

63 citations

Daniel Gomez‐Cardona, Christopher Favazza, Tanya L. Hoskin, Tufia C. Haddad, Matthew P. Goetz +2 more

Endoxifen, an Estrogen Receptor Targeted Therapy: From Bench to Bedside

Endocrinology(2021)10.1210/endocr/bqab191

N/A

0.524DataRank · unranked

32 citations

Joel M. Reid, John R. Hawse, Matthew P. Goetz, Swaathi Jayaraman

Alternating 17β-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER+ Breast Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0112

N/A

0.523DataRank · unranked

8 citations

Peter A. Kaufman, Karthik V. Giridhar, Jonathan D. Marotti, Mary D. Chamberlin, Bradley A. Arrick +7 more

PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER+ Breast Cancer

Molecular Cancer Therapeutics(2024)10.1158/1535-7163.mct-23-0564

N/A

0.470DataRank · unranked

22 citations

Beom-Jun Kim, Aparna Mitra, Craig T. Vollert, Jonathan T. Lei, Diana Fandino +18 more

Phase 1 study of Z-Endoxifen in patients with advanced gynecologic, desmoid, and hormone receptor-positive solid tumors

Oncotarget(2021)10.18632/oncotarget.27887

N/A

0.360DataRank · unranked

10 citations

Geraldine O’Sullivan Coyne, Shivaani Kummar, Jerry M. Collins, Joel M. Reid, Richard Piekarz +18 more

Disruption of estrogen receptor beta’s DNA binding domain impairs its tumor suppressive effects in triple negative breast cancer

Frontiers in Medicine(2023)10.3389/fmed.2023.1047166

N/A

0.292DataRank · unranked

6 citations

Michael J. Emch, Xiyin Wang, Malayannan Subramaniam, Megan L. Hinkle, Esther Rodman +3 more

Blockade of tumor cell-intrinsic PD-L1 signaling enhances AURKA-targeted therapy in triple negative breast cancer

Frontiers in Oncology(2024)10.3389/fonc.2024.1384277

N/A

0.269DataRank · unranked

5 citations

Minzhi Zhang, Mohammad Jalalirad, Roberto Leon Ferre, Royal Shrestha, Tufia C. Haddad +12 more

Bioavailability and Pharmacokinetics of Endoxifen in Female Rats and Dogs: Evidence to Support the Use of Endoxifen to Overcome the Limitations of CYP2D6-Mediated Tamoxifen Metabolism

Drug Metabolism and Disposition(2022)10.1124/dmd.122.000929

N/A

0.241DataRank · unranked

4 citations

Sarah A. Buhrow, Stephanie L. Safgren, Lee Jia, Matthew P. Goetz, Matthew M. Ames +2 more

CYP2D6 activity in patients with metastatic breast cancer treated with single agent tamoxifen: results from ECOG-ACRIN E3108

Breast Cancer Research and Treatment(2024)10.1007/s10549-024-07519-z

N/A

0.174DataRank · unranked

2 citations

Anne O’Neill, Bryan P. Schneider, Todd C. Skaar, Minetta C. Liu, Caroline Lohrisch +9 more

Anti-Neoplastic Activity of Estrogen Receptor Beta in Chemoresistant Triple-Negative Breast Cancer

Cancers(2025)10.3390/cancers17132132

N/A

0.104DataRank · unranked

1 citations

Michael J. Emch, Matthew P. Goetz, John R. Hawse, Xiyin Wang

CHFR expression and sensitivity of breast cancer cells to antimitotic agents in vitro and in the I-SPY trial

npj Breast Cancer(2025)10.1038/s41523-025-00830-y

N/A

0.104DataRank · unranked

1 citations

Karen S. Flatten, Taylor M. Weiskittel, Annapoorna Venkatachalam, Annabella R. Strathman, Olivia K. Rossman +17 more

Lessons learned from a candidate gene study investigating aromatase inhibitor treatment outcome in breast cancer

npj Breast Cancer(2025)10.1038/s41523-025-00733-y

Top 78%

0.104DataRank

Top 78%1 citations

Stefan Winter, Wing‐Yee Lo, Kyriaki Michailidou, Manjeet K. Bolla, Renske Keeman +69 more

Data from Anastrozole Regulates Fatty Acid Synthase in Breast Cancer

(2023)10.1158/1535-7163.c.6543547

N/A

0.104DataRank · unranked

1 citations

James N. Ingle, Krishna R. Kalari, Matthew P. Goetz, Richard M. Weinshilboum, Huanyao Gao +4 more

Oncolytic Urabe mumps virus: A promising virotherapy for triple-negative breast cancer

Molecular Therapy — Oncolytics(2022)10.1016/j.omto.2022.11.002

N/A

0DataRank · unranked

16 citations

Robert J. Stiles, Gennett M. Pike, Laura A. Sikkink, Yongxian Zhuang, Jia Yu +5 more

Role of intratumoral NK cells in triple-negative breast cancer in the FinXX trial and Mayo Clinic cohort.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.510

N/A

0DataRank · unranked

2 citations

Jodi M. Carter, Yaohua Ma, Douglas Hinerfeld, Heather Ann Brauer, Sarah Warren +15 more

Population Pharmacokinetics of Z‐Endoxifen in Patients With Advanced Solid Tumors

The Journal of Clinical Pharmacology(2022)10.1002/jcph.2053

N/A

0DataRank · unranked

0 citations

Andrew T. Ralya, Thomas R. Larson, Renee M. McGovern, Sarah A. Buhrow, Joseph M. Covey +6 more

Clinical Management of Metastatic Hormone Receptor-Positive, HER2-negative Breast Cancer (MBC) After CDK 4/6 inhibitors: A Retrospective Single-Institution Study

Research Square(2022)10.21203/rs.3.rs-1601792/v1

N/A

0DataRank · unranked

0 citations

S. Liddell, Roberto A. Leon‐Ferre, Ciara C. O’Sullivan, Kathryn J. Ruddy, Tufia C. Haddad +6 more

Exploring homologous recombination deficiency thresholds for predicting response to platinum-based treatment in triple negative breast cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.525

N/A

0DataRank · unranked

0 citations

Lauren Lenz, Elizabeth S. Cogan, Erica L. Mayer, Virginia Kaklamani, Vered Stearns +15 more

Association of Anthracycline With Heart Failure in Patients Treated for Breast Cancer or Lymphoma, 1985-2010

JAMA Network Open(2023)10.1001/jamanetworkopen.2022.54669

N/A

0DataRank · unranked

99 citations

Mariana Garcia‐Arango, Harika Dasari, Maria Arciniegas Calle, Effie Adjei, Juan Rico Mesa +8 more

Anastrozole has an Association between Degree of Estrogen Suppression and Outcomes in Early Breast Cancer and is a Ligand for Estrogen Receptor α

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3091

N/A

0DataRank · unranked

41 citations

Junmei Cairns, Vera J. Suman, Lois E. Shepherd, Peter A. Fasching, Tanya L. Hoskin +19 more

Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial

JNCI Journal of the National Cancer Institute(2020)10.1093/jnci/djaa148

N/A

0DataRank · unranked

115 citations

Robert J. Gray, Della Makower, Amir Faghih, Daniel F. Hayes, Charles E. Geyer +23 more

Nodal pCR and overall survival following neoadjuvant chemotherapy for node positive ER+/Her2- breast cancer

Breast Cancer Research and Treatment(2023)10.1007/s10549-023-07152-2

N/A

0DataRank · unranked

11 citations

Tanya L. Hoskin, Courtney N. Day, Amy K. Schulze, Matthew P. Goetz, Judy C. Boughey +1 more

FOXA1 overexpression suppresses interferon signaling and immune response in cancer

Journal of Clinical Investigation(2021)10.1172/jci147025

N/A

0DataRank · unranked

90 citations

Liguo Wang, Ting Wei, Yu‐Tian Xiao, Haoyue Sheng, Hengchuan Su +24 more

Development and validation of a liquid chromatography-mass spectrometry assay for quantification of Z- and E- isomers of endoxifen and its metabolites in plasma from women with estrogen receptor positive breast cancer

Journal of Chromatography B(2023)10.1016/j.jchromb.2023.123654

N/A

0DataRank · unranked

5 citations

Emily J. Koubek, Matthew P. Goetz, Matthew M. Ames, Joel M. Reid, Sarah A. Buhrow

356P Prognostic value of the residual cancer burden after neoadjuvant chemotherapy for invasive lobular breast cancer: An international pooled cohort study

Annals of Oncology(2023)10.1016/j.annonc.2023.09.535

N/A

0DataRank · unranked

1 citations

Helena Earl, Christina Yau, David Cameron, Jean Abraham, Larry Hayward +15 more

A randomized phase 2 non-inferiority trial of (Z)-endoxifen and exemestane + goserelin as neoadjuvant treatment for premenopausal women with ER+/HER2- breast cancer (EVANGELINE).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps633

N/A

0DataRank · unranked

3 citations

Vera J. Suman, Lida A. Mina, Pooja Advani, John George Knecht, Heather Heather Fraser +2 more

Data from Inhibition of ATM Induces Hypersensitivity to Proton Irradiation by Upregulating Toxic End Joining

(2023)10.1158/0008-5472.c.6513031.v1

N/A

0DataRank · unranked

0 citations

Michelle E. Howard, Xinyi Tu, Qian Zhu, Janet M. Denbeigh, Nicholas B. Remmes +12 more

Data from Inhibition of ATM Induces Hypersensitivity to Proton Irradiation by Upregulating Toxic End Joining

(2023)10.1158/0008-5472.c.6513031

N/A

0DataRank · unranked

0 citations

Michelle E. Howard, Xinyi Tu, Qian Zhu, Janet M. Denbeigh, Nicholas B. Remmes +12 more

Regulation of sister chromatid cohesion by nuclear PD-L1

Cell Research(2020)10.1038/s41422-020-0315-8

N/A

0DataRank · unranked

122 citations

Bo Qin, Ann M. Moyer, Somaira Nowsheen, Xinyi Tu, Haidong Dong +6 more

353P Clinical outcomes of treatment with CDK4/6 inhibitors in metastatic breast cancer among carriers of germline pathogenic variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2

Annals of Oncology(2024)10.1016/j.annonc.2024.08.301

N/A

0DataRank · unranked

3 citations

Gerald Choong, R. Koch, Shabnam Yadav, Arya Karki, Ranga Raju Rao +11 more

Anastrozole Dose Escalation for Optimal Estrogen Suppression in Postmenopausal Early-Stage Breast Cancer: A Prospective Trial

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0341

N/A

0DataRank · unranked

4 citations

Vera J. Suman, Karthik V. Giridhar, Kostandinos Sideras, Donald W. Northfelt, Brenda Ernst +15 more

Automated mitotic spindle hotspot counts are highly associated with clinical outcomes in systemically untreated early-stage triple-negative breast cancer

npj Breast Cancer(2024)10.1038/s41523-024-00629-3

N/A

0DataRank · unranked

1 citations

Jodi M. Carter, David M. Zahrieh, Jason P. Sinnwell, Roberto Salgado, Vera J. Suman +10 more

Assessment of Adjuvant Endocrine Therapy With Ovarian Function Suppression by Breast Cancer Index

JAMA Network Open(2025)10.1001/jamanetworkopen.2025.40931

N/A

0DataRank · unranked

2 citations

Yue Ren, Yi Zhang, Natalia Siuliukina, Catherine A. Schnabel, Roswitha Kammler +27 more

Luminal androgen receptor breast cancer subtype and investigation of the microenvironment and neoadjuvant chemotherapy response

UNC Libraries(2025)10.17615/h225-mq92

N/A

0DataRank · unranked

0 citations

Daniel G. Stover, David Zahrieh, Matthew P. Goetz, Eric W. Klee, Lisa A. Carey +15 more

Evaluation of the androgen receptor in patients with ERα-positive early breast cancer treated with adjuvant tamoxifen ± fluoxymesterone

Breast Cancer Research(2025)10.1186/s13058-025-01992-0

N/A

0DataRank · unranked

0 citations

Vera J. Suman, Malvika Solanki, Marie R. Passow, Jordan D. Campbell, Liewei Wang +2 more

Interferon signaling and outcomes in triple-negative breast cancer (TNBC) in FinXX, CALGB 40603 (Alliance) and real-world clinico-genomic data.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.569

N/A

0DataRank · unranked

0 citations

Yi Liu, Sachin Kumar Deshmukh, Jodi M. Carter, Heikki Joensuu, Roberto A. Leon‐Ferre +15 more

Perspectives on Triple-Negative Breast Cancer: Current Treatment Strategies, Unmet Needs, and Potential Targets for Future Therapies

Cancers(2020)10.3390/cancers12092392

N/A

0DataRank · unranked

342 citations

Amber L. Collier, Dasom Lee, Richard Hoefer, Vasilena Zheleva, Lauren L. Siewertsz van Reesema +11 more

Patient-Derived Xenograft Engraftment and Breast Cancer Outcomes in a Prospective Neoadjuvant Study (BEAUTY)

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0641

N/A

0DataRank · unranked

20 citations

Vera J. Suman, Jia Yu, Katelyn Santo, Jason P. Sinnwell, Jodi M. Carter +15 more

Development and Characterization of Novel Endoxifen-Resistant Breast Cancer Cell Lines Highlight Numerous Differences from Tamoxifen-Resistant Models

Molecular Cancer Research(2021)10.1158/1541-7786.mcr-20-0872

N/A

0DataRank · unranked

13 citations

Malayannan Subramaniam, Michael J. Emch, Elizabeth S. Bruinsma, James N. Ingle, Matthew P. Goetz +2 more

Establishment and characterization of immortalized human breast cancer cell lines from breast cancer patient-derived xenografts (PDX)

npj Breast Cancer(2021)10.1038/s41523-021-00285-x

N/A

0DataRank · unranked

12 citations

Jordan Grainger, Peter T. Vedell, Jia Yu, Ann M. Moyer, Huanyao Gao +9 more

Anastrozole Regulates Fatty Acid Synthase in Breast Cancer

Molecular Cancer Therapeutics(2021)10.1158/1535-7163.mct-21-0509

N/A

0DataRank · unranked

11 citations

James N. Ingle, Krishna R. Kalari, Matthew P. Goetz, Richard M. Weinshilboum, Huanyao Gao +4 more

Long-term outcomes of patients with node-negative (N0), triple-negative breast cancer (TNBC) who did not receive adjuvant chemotherapy according to stromal TILs (sTILs).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.548

N/A

0DataRank · unranked

0 citations

Jodi M. Carter, David W. Hillman, Kathleen Tenner, David M. Zahrieh, Minetta C. Liu +7 more

Aurora-A kinase oncogenic signaling mediates TGF-β-induced triple-negative breast cancer plasticity and chemoresistance

Oncogene(2021)10.1038/s41388-021-01711-x

N/A

0DataRank · unranked

103 citations

Tufia C. Haddad, Jeffrey L. Salisbury, Derek C. Radisky, Minzhi Zhang, Mark A. Schroeder +16 more

Luminal androgen receptor breast cancer subtype and investigation of the microenvironment and neoadjuvant chemotherapy response

NAR Cancer(2022)10.1093/narcan/zcac018

N/A

0DataRank · unranked

43 citations

Roberto A. Leon‐Ferre, Jason P. Sinnwell, David Zahrieh, Vera J. Suman, Filho Otto Metzger +15 more

Identification of Src Family Kinases as Potential Therapeutic Targets for Chemotherapy-Resistant Triple Negative Breast Cancer

Cancers(2022)10.3390/cancers14174220

N/A

0DataRank · unranked

24 citations

Jia Yu, Yongxian Zhuang, Xiaoyang Fan, Raven J. Reddy, Jason P. Sinnwell +7 more

Quantitative analysis of tyrosine phosphorylation from FFPE tissues reveals patient specific signaling networks

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.09.10.291922

N/A

0DataRank · unranked

2 citations

Danielle M. Burgenske, Ann C. Mladek, Katrina K. Bakken, Jenevieve Kuang, Judy C. Boughey +7 more

Matthew P. Goetz

Indexed papers

Top data-sharing exemplar

Papers